* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Incorporating Periodontal Medicine into Clinical Practice Maria
Survey
Document related concepts
Transcript
Periodontal Disease: Therapeutic Strategies • Elimination of bacterial infection • Modulation of host response – mechanical removal of infectious – systemic delivery of hostagent modulating drugs – Triclosan toothpaste • NSAIDS – Antiseptic rinse/irrigation • Periostat® (SDD) – surgical reduction of periodontal • Bisphosphonates pockets – local delivery of host modulating – topical antimicrobials • Actisite® Modulation of risk factors drugs • Emdogain • Periochip –smoking cessation • Growth Factors • Atridox® –diabetic control • Arestin • BMPs –improved oral hygiene – systemic antimicrobials –corrective dentistry –improved nutrition –stress reduction –weight loss These Strategies are Complementary Colgate Total • Only toothpaste to contain triclosan, an antibacterial ingredient – Adheres to oral mucosa (soft and hard tissues) for up to 12 hours • Only toothpaste approved by FDA and Accepted by ADA for treatment of gingivitis, plaque, caries, calculus and oral malodor. Colgate Total Placebo controlled studies in smokers (Kerdvongbundit and Wikesjo, J Clin Periodontol. 2003;30(12):1024-30) and subjects with recurrent periodontitis (Furuichi et al., J Clin Periodontol. 1999;26(2):63-6) suggest that an oral hygiene regimen including a triclosan/copolymer dentrifice may sustain the short-term effect of non-surgical therapy in smokers and improve on healing after non-surgical treatment of recurrent periodontitis as measured by improvements in gingival inflammation, probing depth reductions and probing attachment levels. Colgate Total Triclosan in vitro has anti-inflammatory effects inhibiting cytokine (IL-1b and TNF-a) stimulated production of prostanoinds (PGE2) from monocytes and reducing the activity of an enzyme responsible for the production of prostanoids (COX-2) in culture, as well as inhibiting bone resorption in a parathyroidhormone-induced release of calcium from bone cultures. Intervention • Can periodontal therapy affect glycemic control in people with diabetes? • The first case series to demonstrate this was published in 1960 where type 1 diabetics with periodontitis had a reduction in required insulin doses following: – – – – Scaling and root planing Localized gingivectomy Selected tooth extraction Combined with penicillin and streptomycin Williams and Mahan, JAMA, 1960 Preliminary Intervention Trials Meta-analysis of 10 intervention trials included 456 patients • The decrease in absolute HbA1c values was ~0.4% • The addition of systemic antibiotics resulted in an average absolute reduction of 0.7% • Numerous deficiencies – Small sample sizes – Mixing type 1 and 2 diabetics – Confounding effects of smoking, BMI, medications, etc. • Additional studies are needed to determine whether periodontal therapy provides a significant benefit on glycemic control Janket S-J et al., J Dent Res, 2005 Raising The Bar • Glycated Hemoglobin – Lower and lower to prevent diabetic complications • Oral Care – Optimal to reduce insulin resistance and to allow for metabolic control – Improved to prevent long term complications – What is complete treatment, who is well controlled? • Is a 5 mm probing depth too much disease? • Is gingivitis too much disease?